在慢性斑块牛皮中抑制受体相互作用蛋白激酶1:一个多中心,随机,双盲,安慰剂控制的研究
Valerie J Ludbrook1, David C Budd2, Katie Thorn3
1Clinical Pharmacology and Experimental Medicine, GSK, Gunnels Wood Rd, Stevenage, Hertfordshire, SG1 2NY, UK. valerie.j.ludbrook@gsk.com.
Dermatology and therapy
|February 19, 2024
概括
与安慰剂相比,RIPK1抑制剂GSK2982772在斑块性牛皮患者中表现出良好的耐受性,但并没有显著改善临床结果. 进一步研究银病的RIPK1抑制是有必要的.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 受体相互作用蛋白激酶1 (RIPK1) 与牛皮等炎症性疾病有关.
- 以前的研究表明,RIPK1抑制与改善药物度的潜在有效性.
研究的目的:
- 评估GSK2982772在中度至重度斑块牛皮的疗效,安全性,药理动力学和药理动力学.
- 评估高剂量 (每日一次960毫克) 的GSK2982772的修饰释放配方.
主要方法:
- 一项为期12周的多中心,随机,双盲,安慰剂控制的研究 (NCT04316585).
- 29名中度至重度斑块性牛皮患者随机分配给GSK2982772 (N=19) 或安慰剂 (N=10).
- 评估牛皮区域严重性指数 (PASI) 评分,安全性和药理动力学.
主要成果:
- GSK2982772被耐受性良好,达到比以前配方更高的低谷度.
- 观察到几乎完全的 RIPK1 标参与和炎症性细胞因子的适度减少.
- 在GSK2982772和安慰剂组之间,12周的PASI 75反应没有显著差异.
结论:
- GSK2982772在中度至重度斑块性牛皮的患者中没有产生有意义的临床改善.
- 药理学标记表明局部药物暴露,但这并没有转化为临床疗效.
- 这项研究不支持使用这种RIPK1抑制剂治疗斑块性牛皮.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


